PlainRecalls
FDA Drug Low Class III Terminated

Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint Laboratories, NDC 68001-313-56

Reported: August 17, 2022 Initiated: July 22, 2022 #D-1334-2022

Product Description

Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint Laboratories, NDC 68001-313-56

Reason for Recall

Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.

Details

Units Affected
4162 cartons
Distribution
Distributed in Ohio
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint Laboratories, NDC 68001-313-56. Recalled by Teva Pharmaceuticals USA Inc. Units affected: 4162 cartons.
Why was this product recalled?
Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 17, 2022. Severity: Low. Recall number: D-1334-2022.